Schonfeld Strategic Advisors LLC Artivion, Inc. Transaction History

Schonfeld Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$10.01 - $13.9 $101,181 - $140,501	10,108 New	10,108 $122,000
Q1 2021 May 17, 2021	SELL	$22.07 - $26.31 $214,079 - $255,207	-9,700 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$16.76 - $23.74 $120,169 - $170,215	-7,170 Reduced 42.5%	9,700 $229,000
Q3 2020 Nov 16, 2020	BUY	$16.35 - $21.4 $275,824 - $361,018	16,870 New	16,870 $0
Q4 2019 Feb 14, 2020	SELL	$22.45 - $27.09 $442,265 - $533,673	-19,700 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$25.98 - $30.8 $844,350 - $1 Million	-32,500 Reduced 62.26%	19,700 $534,000
Q2 2019 Aug 14, 2019	SELL	$27.55 - $32.39 $5.25 Million - $6.18 Million	-190,700 Reduced 78.51%	52,200 $1.56 Million
Q1 2019 May 15, 2019	BUY	$25.85 - $30.47 $6.28 Million - $7.4 Million	242,900 New	242,900 $7.09 Million

178

36.1M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.25B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.